ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis

ASGE Standards of Practice Committee, James L Buxbaum, Syed M Abbas Fehmi, Shahnaz Sultan, Douglas S Fishman, Bashar J Qumseya, Victoria K Cortessis, Hannah Schilperoort, Lynn Kysh, Lea Matsuoka, Patrick Yachimski, Deepak Agrawal, Suryakanth R Gurudu, Laith H Jamil, Terry L Jue, Mouen A Khashab, Joanna K Law, Jeffrey K Lee, Mariam Naveed, Mandeep S Sawhney, Nirav Thosani, Julie Yang, Sachin B Wani, ASGE Standards of Practice Committee, James L Buxbaum, Syed M Abbas Fehmi, Shahnaz Sultan, Douglas S Fishman, Bashar J Qumseya, Victoria K Cortessis, Hannah Schilperoort, Lynn Kysh, Lea Matsuoka, Patrick Yachimski, Deepak Agrawal, Suryakanth R Gurudu, Laith H Jamil, Terry L Jue, Mouen A Khashab, Joanna K Law, Jeffrey K Lee, Mariam Naveed, Mandeep S Sawhney, Nirav Thosani, Julie Yang, Sachin B Wani

Abstract

Each year choledocholithiasis results in biliary obstruction, cholangitis, and pancreatitis in a significant number of patients. The primary treatment, ERCP, is minimally invasive but associated with adverse events in 6% to 15%. This American Society for Gastrointestinal Endoscopy (ASGE) Standard of Practice (SOP) Guideline provides evidence-based recommendations for the endoscopic evaluation and treatment of choledocholithiasis. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was used to rigorously review and synthesize the contemporary literature regarding the following topics: EUS versus MRCP for diagnosis, the role of early ERCP in gallstone pancreatitis, endoscopic papillary dilation after sphincterotomy versus sphincterotomy alone for large bile duct stones, and impact of ERCP-guided intraductal therapy for large and difficult choledocholithiasis. Comprehensive systematic reviews were also performed to assess the following: same-admission cholecystectomy for gallstone pancreatitis, clinical predictors of choledocholithiasis, optimal timing of ERCP vis-à-vis cholecystectomy, management of Mirizzi syndrome and hepatolithiasis, and biliary stent therapy for choledocholithiasis. Core clinical questions were derived using an iterative process by the ASGE SOP Committee. This body developed all recommendations founded on the certainty of the evidence, balance of risks and harms, consideration of stakeholder preferences, resource utilization, and cost-effectiveness.

Copyright © 2019. Published by Elsevier Inc.

Figures

Figure 1.
Figure 1.
Forest plot of randomized trials comparing endoscopic sphincterotomy followed by large balloon dilation versus endoscopic sphincterotomy for stone clearance.
Figure 2.
Figure 2.
A, Proportion of large and difficult stone clearance by intraductal therapy stratified by papillary dilation. B, Proportion of large and difficult stone clearance by conventional therapy stratified by papillary dilation.
Figure 2.
Figure 2.
A, Proportion of large and difficult stone clearance by intraductal therapy stratified by papillary dilation. B, Proportion of large and difficult stone clearance by conventional therapy stratified by papillary dilation.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する